US Stock MarketDetailed Quotes
MBX MBX Biosciences
- 18.500
- +1.990+12.05%
Close Nov 22 16:00 ET
- 18.500
- 0.0000.00%
Post 20:01 ET
618.22MMarket Cap-11191P/E (TTM)
19.000High16.750Low127.31KVolume16.750Open16.510Pre Close2.25MTurnover1.25%Turnover RatioLossP/E (Static)33.42MShares27.50052wk High2.28P/B188.70MFloat Cap15.31052wk Low--Dividend TTM10.20MShs Float27.500Historical High--Div YieldTTM13.63%Amplitude15.310Historical Low17.662Avg Price1Lot Size
MBX Biosciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | |||||
| Cash flow from continuing operating activities | -89.80%-14.66M | -38.30%-31.98M | -11.15M | -7.73M | -23.12M |
| Net income from continuing operations | -78.51%-18.14M | -24.60%-32.56M | ---8.84M | ---10.16M | ---26.14M |
| Operating gains losses | ---- | -92.90%69K | ---- | ---- | --972K |
| Depreciation and amortization | 87.50%75K | 180.36%157K | --41K | --40K | --56K |
| Other non cash items | 12.50%27K | -77.16%95K | --25K | --24K | --416K |
| Change In working capital | 54.63%2.77M | -156.98%-735K | ---2.86M | --1.79M | --1.29M |
| -Change in prepaid assets | -562.60%-569K | -32.36%-1.05M | ---1.32M | --123K | ---791K |
| -Change in payables and accrued expense | 98.24%3.38M | -78.47%457K | ---1.49M | --1.7M | --2.12M |
| -Change in other current assets | ---- | 80.95%-8K | ---- | ---- | ---42K |
| -Change in other current liabilities | -8.57%-38K | ---137K | ---35K | ---35K | --0 |
| Cash from discontinued investing activities | |||||
| Operating cash flow | -89.80%-14.66M | -38.30%-31.98M | ---11.15M | ---7.73M | ---23.12M |
| Investing cash flow | |||||
| Cash flow from continuing investing activities | -441.73%-100.79M | -171.03%-30.93M | -28.96M | -18.61M | -11.41M |
| Net PPE purchase and sale | -159.09%-57K | 70.75%-129K | ---55K | ---22K | ---441K |
| Net investment purchase and sale | -442.06%-100.73M | -180.75%-30.8M | ---28.9M | ---18.58M | ---10.97M |
| Cash from discontinued investing activities | |||||
| Investing cash flow | -441.73%-100.79M | -171.03%-30.93M | ---28.96M | ---18.61M | ---11.41M |
| Financing cash flow | |||||
| Cash flow from continuing financing activities | 244.27%235.81M | 50.27%69.22M | 19K | 68.5M | 46.06M |
| Net issuance payments of debt | ---- | --0 | ---- | ---- | --10M |
| Net preferred stock issuance | ---- | 87.74%68.51M | --0 | ---- | --36.49M |
| Proceeds from stock option exercised by employees | -282.35%-31K | 2,363.33%739K | --19K | --17K | --30K |
| Net other financing activities | ---2.2M | 93.45%-30K | --0 | ---- | ---458K |
| Cash from discontinued financing activities | |||||
| Financing cash flow | 244.27%235.81M | 50.27%69.22M | --19K | --68.5M | --46.06M |
| Net cash flow | |||||
| Beginning cash position | -56.04%12.5M | 90.93%24.21M | --70.61M | --28.44M | --12.68M |
| Current changes in cash | 185.45%120.36M | -45.25%6.31M | ---40.08M | --42.17M | --11.53M |
| End cash Position | 88.18%132.87M | 26.08%30.52M | --30.52M | --70.61M | --24.21M |
| Free cash flow | -90.00%-14.72M | -36.26%-32.11M | ---11.2M | ---7.75M | ---23.56M |
| Currency Unit | USD | USD | USD | USD | USD |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
